In the present study, we have proposed a COVID-19-cellular immunity test based on the cytokine release assay (CRA) in whole blood in response to SARS-CoV-2 S protein-specific to evaluate IFN-γ levels and other cytokines and chemokines associated with different degrees of exposition and COVID-19 infection. The gene discussed is IFNG; the disease is COVID-19.